Equity Overview
Price & Market Data
Price: $18.90
Daily Change: -$0.36 / 1.90%
Daily Range: $18.89 - $19.45
Market Cap: $244,248,290
Daily Volume: 99,544
Performance Metrics
1 Week: 5.95%
1 Month: 2.58%
3 Months: 0.58%
6 Months: -5.22%
1 Year: 6.42%
YTD: 6.60%
Company Details
Employees: 111
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.